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INTRODUCTION
There are some situations that predispose to-
wards a state of hypercoagulability. In nephrotic
syndrome, in the puerperal gestational cycle and in
states of thrombophilia, alterations occur in coagu-
lation factors and in the physiological inhibitions
of coagulation that may lead to the formation of
thrombus.1-4 A thrombus situated in the inferior
vena cava, at the junction of the renal veins, may
compromise renal function through the pressure
increase. Although deep vein thrombosis is easy to
recognize, the etiologic diagnosis is still complicated,
mainly due to the existence of many predisposal
factors. Thus, knowledge of deep vein thrombosis
physiopathology and the risk factors related to the
clinic condition are important, so that a standard
diagnostic study and suitable therapy may be in-
troduced as soon as possible, avoiding complica-
tions such as pulmonary embolism.
This work has the aim of reporting on a clinic
case involving a patient that presented a family his-
tory of thromboembolism and developed deep vein
thrombosis in a lower limb and vena cava throm-
bosis during the puerperal gestational cycle, display-
ing nephrotic syndrome as the main complication.
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CASE REPORT
The patient, a white 19-year-old married
housewife from São Paulo, Brazil, entered the
hospital complaining of pains and swelling in
the right leg. She had suffered these pains for
three days. Her clinical history showed that she
had had a baby via vaginal delivery in hospital,
without complications, one month and half ear-
lier. She was primipara and this was her first
gestation. During the gestation, she did prena-
tal screening, and apparently there were no ab-
normalities.
In the immediate puerperium, she pre-
sented urinary infection that was treated using
norfloxacin. The pain that led her to the hospi-
tal started in the right knee and thereafter fol-
lowed a descending course to the foot, followed
by the development of accentuated edema. She
also felt paresthesia, burning, and the sensation
of fever, anorexia, and asthenia.
In relation to the various systems, she reported
frontal headache, rotatory vertigo when sudden
movements were made, dry cough, pain in the
knees, and alteration in the color of the hands,
that sometimes were pale, reddish or purplish.
She denied having antecedents of hepatitis,
diabetes, tuberculosis, hypertension, sexually trans-
mitted diseases, drug taking, and surgeries or previ-
ous internment. As far as the family history was
concerned, she mentioned that her father had hy-
pertension and diabetes, and he had had deep vein
thrombosis in the right lower limb when he was
38. He was treated using anticoagulant and elastic
socks. He died of a cerebral vascular accident when
he was 55. The mother (47 years old) was alive and
healthy. The patient had three healthy brothers, and
four sisters. The eldest one, 32, had had three mis-
carriages and during her last gestation she presented
thrombosis in a lower limb and had to be submit-
ted to anticoagulant therapy for six months. She
denied having antecedents of tumors, malforma-
tions, or connective tissue disorders.
During the examination in the hospital, the
patient showed a regular general state, cutaneous
paleness, colorless mucous, and was hydrous,
acyanotic, without icterus, without fever, eupneic,
orientated and contacting normally. Blood pres-
sure was 110x70 mmHg; cardiac frequency 120
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bpm; respiratory rate 15 rpm. In her face, a trace
of gestational chloasma could be seen, with lymph
nodes not evident, thyroid not evident and ab-
sence of jugular stasis (Figure 1). She did not
present cardiorespiratory or abdominal alterations.
In the superior extremities she did not present any
abnormality. In the inferior extremities, reticular
livedo could be seen in both limbs, with edema
and significant pain in the right lower limb from
the base of the thigh, with pasting and difficulty
in dorsiflexion of the foot (Homans sign). The
left lower limb was normal (Figures 2 and 3). Pal-
pation of the peripheral pulses (popliteus, pedious)
showed that the left side was normal and the right
side, slightly decreased.
The patient was interned with the following
diagnostic theories: puerperal hypercoagulability,
antiphospholipid antibody syndrome, nephrotic
syndrome, puerperal anemia, infection of the uri-
nary system and connective tissue disorder. At the
time of internment, laboratory tests showed the
following: urine I: 8,800 leukocytes/ml; hematuria:
16,000/ml, with erythrocytic dimorphism, some
hyaline casts, some bacteria, many epithelial cells,
positive mucus filaments, negative glucose and pro-
teinuria (8.2 g/l). Blood count: 15,800 leukocytes/
mm3; with the differentiation being 1% band
forms, 94% segmented, 1% eosinophils, 0%
basophils, 3% lymphocytes and 1% monocytes;
microcytic hypochromic anemia with hemoglobin
of 7.8 g/dl; hematocrit of 27% and platelets:
170,000 mm3.
The coagulation tests presented pro-
thrombin time (PT) = 74%; bleeding time (BT)
= 3 minutes; activated partial thromboplastin
time (APTT) = 32.9 s; ratio APTT patient/
APTT pool = 1.18.
The biochemistry of the blood presented:
creatine = 1.1 mg/dl; potassium = 4.8 Eq/l; so-
dium = 135 mEq/l; total bilirubin = 0.4 mg/dl
(direct = 0.2 md/dl); glucose = 139 mg/dl.
The venous gasometry presented: pH =
7.37; pCO
2
 = 36 mmHg; pO
2
 = 35 mmHg;
HCO
3
 = 23 mmol/L; BE = 3.
Proteinuria (24 hours) = 3.23 g in a vol-
Figure 1. Lower limbs. Observe reticular livedo and right
lower limb edema.
Figure 3. Left renal Doppler ultrasound : inferior cava thrombosis.
Figure 2. Right renal Doppler ultrasound showing inferior cava thrombosis including the area of the junction of the renal veins.
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ume of 320 ml (10.1 g/L); creatinine depura-
tion = 51 ml/min; ALT = 17u/L; AST = 21 u/
L; CK = 56 u/L; CKMB =20 u/L. Direct and
indirect Coombs were negative. The dosage of
antithrombin III was dosed using the functional
method with chromogen substrate S2765, with
a result of 135% of activity (normal range: 80
to 120%).
From the clinical and laboratory data, the
following could be diagnosed: deep vein
thrombosis, urinary infection, nephrotic syn-
drome, and probable systemic lupus erythema-
tosus. Anticoagulant intravenous therapy with
heparin was introduced for 6 days, with war-
farin sodium (MarevanR) from the third day.
Anticoagulant therapy control was performed
using a daily dosage of APTT and, even with
daily dosages of 1,600 u/h of heparin, the
APTT did not alter.
Treatment using prednisone (MeticortenR
60 mg/day) was also introduced. On the tenth
day, renal Doppler ultra-sound was requested,
and inferior vena cava thrombosis was found,
including the area of the junction of the renal
veins. It was not possible to identify flux in this
topography. The kidneys were morphologically
preserved, with normal dimensions, diffuse
decrease of their echo texture and loss in paren-
chyma-sinus differentiation. Neither hydro-
nephrosis nor calculus was identified. The right
kidney measured 11.6 x 4.1 cm at its largest
diameters and the left kidney measured 10.4 x
4.9 cm (Figure 4).
Antinuclear factor, anti-ENA (extractable
nuclear antigens), anti-DNA native, anti-
cardiolipin, lupus anticoagulant and cryoglobu-
lin were negative.
On the fourteenth day, serum albumin (1.58
g/dL) was observed and therapy of three flasks
of albumin EV was introduced. The 24-hour
proteinuria presented a decrease (from 10.1 to
1.1 g/L – 1.36g in a volume of 1240 ml corre-
sponding to 24 hours) and the creatinine depu-
ration increased (from 51 ml/min to 69 ml/min).
The urine test I that had presented proteinuria
of 8.2 g/L went to 0.9 g/L and the erythrocytes
that were 100/field decreased to 10/field.
The patient was interned for 28 days with
the following evolution. On the second day of
internment there was an intensification of the
articulation pains in the right lower limb and
she also started to present discrete edema in the
left lower limb. Appearance of malar rash, bi-
lateral bipalpebral edema and fever were also
observed. The pain had progressive improve-
ment with medications, but the generalized
edema was kept till the fourteenth day, when it
started to regress slowly. By the time she was
discharged, on the twenty-eighth day, there was
no more pain or edema.
The nephrotic syndrome progressed with
improvement on the fourteenth day, when re-
mission of the thromboembolic condition
started. The patient left the hospital with no
symptoms. On the day she was discharged, a
new ultrasound of the renal veins and vena cava
was done, revealing the presence of normal-
caliber vena cava and renal veins, showing no
signs of thrombosis. Both the left and right kid-
neys presented normal configuration. The an-
ticoagulant medication was maintained and
planned to continue for 6 months, using war-
farin sodium (MarevanR 2 tablets a day) and
prednisone (MeticortenR 10 mg a day).
The patient was clinically followed up with
periodic checks of PT and INR (international
normative relation) between 2.0 and 3.0 (ap-
proximately 30% of the prothrombin activity),
and orientated in relation to the risks for new
thromboembolic phenomena.
A month after she left the hospital, the pa-
tient presented a new condition in the deep vein
system, now in the left lower limb. New treat-
ment with anticoagulant was introduced and
clinical tests were requested, which presented
the following values:
Protein C activity = 77% (normal range:
70 to 130%); free protein S in the plasma: 25%
(normal = 70 to 130%); APTT =45.9 seconds
(APTT pool normal plasma = 29.2 seconds);
relation APTT patient/APTT pool = 1.57;
dRVVT (dilute Russell’s Viper Venom test) =
46.2 seconds; normal plasma = 30.5 seconds;
relation dRVVT patient/dRVVT pool normal
plasma = 1.31 (lupus anticoagulant; relation of
dRVVT > 1.14), PNP test (platelet neutraliza-
tion process); PNP patient = 43.2 seconds; PNP
control = 51.8 seconds; reference value = PNP
extension control > PNP patient = lupus anti-
coagulant; ATIII = 92% (normal = 80 to 120%);
resistance test to activated Protein C in addition
to plasma deficient of factor V: result = 52.3,
indicating absence of resistance to protein C;
Leiden factor V: absent; homocysteine = 36.5
mol/l (normal = 5.5 to 17.0 mol/L).
Analyzing the clinical and laboratory data,
a diagnosis of antiphospholipid antibody syn-
drome and hyperhomocysteinemia was made,
and the patient was treated with anticoagulant
therapy and frequent clinical attendance.
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DISCUSSION
Reviewing the risk factors for venous
thromboembolic disease, it can be seen that this
is about five times more frequent during preg-
nancy, and is one important reason for obstet-
ric morbidity and mortality.1 The risk is present
throughout pregnancy, but it becomes increased
especially in the last trimester as well as in the
five weeks after childbirth. The main reason for
this is the venous stasis associated with the in-
crease in the level of coagulation factors. On
the other hand, the factors that block coagula-
tion are decreased.1-5 As this patient was in the
late puerperium, and might have been in a state
of hypercoagulability, the occurrence of deep
vein thrombosis can be explained.
The nephrotic syndrome may lead to
hypercoagulability as a consequence of the al-
teration in the level of coagulation factors, in-
cluding a decrease in factors IX, X, and XII;
elevation especially of the levels of the factors V
and VIII, fibrinogen, beta-thromboglobulin and
platelets; decrease in coagulation inhibitors, such
as proteins C and S and ATIII; and increase in
platelet aggregation.Figure 4. Showing the probable location of the thrombosis. V. Ren: Renal vein; VCI: Inferior cava vein.
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Table. Clinical states that may predispose to thromboembolic phenomena
Deficiency
ATIII Deficiency
Protein C Deficiency
Protein S Deficiency
Leiden Factor V
Hyperhomocysteinemia
Antiphospholipid Antibody
Etiology
Dominant autosomal heredity
Acquired: nephrotic syndrome,
anti-contraceptive intake, hepatic
cirrhosis);
Dominant autosomal heredity
Mutation in the point G1691A of
the protein factor V
Recessive autosomal heredity
leading to an alteration of the
enzyme cystothionin-b-synthetase
Acquired: colabamine, folate or
pyridoxine deficiency; chronic renal
insufficiency, methotrexate or anti-
convulsant intake
Unknown
Clinical Condition
Thrombosis started in the
puberty or adult
Venous thromboembolism
Similar to the deficiency of protein C
Mental deficiency, skeletal abnor-
malities; arterial and venous throm-
bosis; recurrent venous thrombosis;
Risk factor for severe myocardial
infarction
Antiphospholipid antibody syn-
drome (recurrent venous or arterial
thrombosis; fetal death with miscar-
riage and thrombocytopenia)
Diagnosis
Chromogen substrate
Protein C activity
(immunoenzymatic or amidolysis of
the chromogen substrate
Protein S free in the plasma
Activated protein C resistance;
Molecular test
High pressure liquid
chromatography
Positivity at least in these two tests:
prolonged APTT, that is not corrected
with the addition of fresh plasma rich
in coagulation factors, dRVVT (dilute
Russell’s Viper Venom test) and Kao-
lin clotting time of coagulation)
Leiden factor V may be associated with
complications during pregnancy, such as throm-
boembolism, pre-eclampsia, miscarriage, and
delay in the intrauterine growth. For this rea-
son, there are some authors that believe it is
important to research Leiden factor V in women
who have a family history of thromboembo-
lism and wish to become pregnant.6,7
During pregnancy, the physiological state
of hypercoagulability in association with the
ATIII acquired deficiency increases the risk of
pulmonary thromboembolism to 70%. Hence
it is important to measure hypercoagulability
parameters during gestation, such as ATIII and
ATIII thrombin complex.4
Moderate or severe hyperhomocysteinemia
is a risk factor for myocardial infarction, arte-
rial disease or venous thrombosis in young peo-
ple, and for recurrent venous thrombosis. Due
to our patient’s presentation of recurrent venous
thrombosis, young age and increased
homocysteinemia levels, it could be concluded
that she had moderate hyperhomocysteinemia.
SLE was considered as a diagnostic hypoth-
esis in this case because the patient was present-
ing nephrotic syndrome that started during the
puerperium, in association with the presence
of erythematous lesion on the face, Raynaud,
reticular livedo, and arthralgia in the knee.10
Prednisone was introduced as a result of this
diagnostic hypothesis, which was not confirmed
because of the clinical evolution, the absence of
clinical criteria, and the serological findings.
Nevertheless, this diagnostic hypothesis may
only be totally excluded after long-term
attendance.
The antiphospholipid antibody syndrome
(AFAS) is a clinical entity that leads to a state of
hypercoagulability. It is characterized by recur-
rent venous or arterial thrombosis, fetal death
through miscarriage, and thrombocytopenia
associated with the presence of circulating
antiphospholipid antibodies (AFA) represented
by the anticardiolipin (ACL) and/or lupus
anticoagulant (LA).1,11 In just 50% of AFAS
cases are both the tests positive, which makes it
necessary to perform the two tests in clinically
suspicious cases. LA is considered positive when
at least two of the following tests are positive:
prolonged PTT that is not corrected with the
addition of fresh plasma rich in coagulation fac-
tors;14 dRVVT (dilute Russell’s Viper Venom
test); and Kaolin coagulation clotting time. In
this way, this antibody may be a risk marker for
thrombosis or have an important direct role in
the pathogenesis of this complication.
When validating the thrombus, the circu-
lating AFA may be negative, which makes it ob-
ligatory to repetitively research the antibodies in
the thrombotic phenomena.12 The relation be-
tween AFA and thrombosis was suggested by
Bowie in 1963, and from then on, there have
been many studies confirming this relation.1,12 It
has been noticed that women with a history of
recurrent miscarriages have 15% AFA incidence
and a 90% probability of pregnancy failure.1,12
The complications in a gestation followed by the
antiphospholipid antibody syndrome are arterial
or venous thrombosis, thrombocytopenia, pre-
eclampsia, toxemia, low fecundation rates,
neurological, cardiological, renal and hepatic
alterations, higher risk of postpartum depression
and postpartum serositis syndrome.1,12,13 The
renal complications associated with the presence
of AFA are hypertension, renal insufficiency, renal
venous thrombosis and renal infarction. Patients
with positive AFA symptoms should receive anti-
thrombotic therapy, although the time and length
of the treatment are still not well determined.
The recurrence risk for thrombosis is high after
an interruption in therapy, justifying the pro-
longed anticoagulation. However, the
hemorrhage risk cannot be neglected either.
Occasionally, in some cases, the AF antibodies
extend the PT and the INR, making proper con-
trol of the coagulation difficult.11-13
AFAS was considered in the case of this pa-
tient because of the presence of venous throm-
bosis and reticular livedo, and also because her
sister presented a history of recurrent miscarriages
and deep vein thrombosis. The fact that the pa-
tient had her parturition at full term, with ab-
sence of thrombocytopenia and anticardiolipin
antibody, negative LA at first, and normal PTT,
made this diagnosis seem improbable. However,
as the patient presented recurrent thrombosis and
positive lupus anticoagulant verified by many
techniques, the diagnosis of antiphospholipid
antibody syndrome was confirmed.
The gestational puerperal cycle is a transi-
tory thrombotic state that may predispose to
thromboembolic phenomena, whose major
complication is the pulmonary thromboembo-
lism, which may be fatal.14 Patients with throm-
bosis associated with a family history of this
should be investigated (ATIII dosage, Leiden
factor V, proteins C and S, homocysteine, AFA)
and alerted to the risk of developing throm-
boembolic phenomena (Table) in the face of
puerperium risk factors for nephrotic syndrome,
surgeries, and immobilization.14
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CONTEXTO: A gestação é acompanhada de um
estado fisiológico de hipercoagulabilidade.
Fenômenos de Trombose podem ocorrer.
OBJETIVO: Relatar um caso clínico envolvendo
uma paciente que apresentava história
importante de trombifilia familiar, e que
desenvolveu trombose venosa profunda no
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membro inferior e trombose da veia cava du-
rante o ciclo gravídico-puerperal, apresentando
síndrome nefrótica como principal complicação.
TIPO DE ESTUDO: Relato de caso.
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Puerpério. Gravidez. Trombose da veia cava.
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